Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes

Signal Transduct Target Ther. 2020 Dec 11;5(1):287. doi: 10.1038/s41392-020-00360-y.

Abstract

Fulminant myocarditis (FM) is characterized by a rapid progressive decline in cardiac function and a high mortality rate. Since the first report of FM patients in the 1980s, several clinical trials and research studies have been published increasing our knowledge regarding FM. Currently, the diagnosis of FM depends on various techniques including electrocardiography, echocardiography, endomyocardial biopsy, and cardiac magnetic resonance. The development of mechanical circulation support (MCS) devices and progress in our understanding of the pathophysiological mechanisms underlying FM, treatment regimens have evolved from simple symptomatic treatment to a life support-based comprehensive treatment approach. The core mechanism underlying the development of FM is the occurrence of an inflammatory cytokine storm. This review provides a comprehensive account of the current understanding of FM pathophysiology and knowledge regarding its etiology, pathophysiology, treatments, and outcomes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biopsy
  • Cytokine Release Syndrome* / complications
  • Cytokine Release Syndrome* / diagnosis
  • Cytokine Release Syndrome* / mortality
  • Cytokine Release Syndrome* / therapy
  • Echocardiography*
  • Electrocardiography*
  • Heart-Assist Devices*
  • Humans
  • Myocarditis* / diagnosis
  • Myocarditis* / etiology
  • Myocarditis* / mortality
  • Myocarditis* / therapy